US Patent 7780967 Reduced toxicity Clostridial toxin pharmaceutical compositions

Patent 7780967 was granted and assigned to Allergan, Inc. on August, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Allergan, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7780967

Date of Patent

August 24, 2010

Patent Application Number

10359828

Date Filed

February 7, 2003

Patent Citations Received

‌

US Patent 11911449 Albumin-free botulinum toxin formulations

Patent Primary Examiner

‌

Vanessa L. Ford

Patent abstract

A Clostridial toxin pharmaceutical composition comprising a Clostridial toxin, such as a botulinum toxin and a polysaccharide, such as a hydroxyethyl starch, wherein the pharmaceutical composition has a reduced toxicity. The Clostridial toxin pharmaceutical composition can be essentially free of any blood or serum derived proteins, filtrates or fractions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7780967 Reduced toxicity Clostridial toxin pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API